Stan Berenshteyn
Stock Analyst at Wells Fargo
(2.08)
# 2,898
Out of 4,945 analysts
65
Total ratings
50%
Success rate
-9.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HCAT Health Catalyst | Maintains: Overweight | $10 → $6 | $3.07 | +95.44% | 6 | Aug 11, 2025 | |
DOCS Doximity | Maintains: Equal-Weight | $62 → $65 | $62.98 | +3.21% | 12 | Aug 8, 2025 | |
AMWL American Well | Maintains: Overweight | $15 → $12 | $7.18 | +67.13% | 4 | Aug 7, 2025 | |
OMCL Omnicell | Maintains: Overweight | $37 → $40 | $31.34 | +27.63% | 17 | Jul 21, 2025 | |
VEEV Veeva Systems | Maintains: Overweight | $285 → $300 | $274.36 | +9.35% | 6 | May 29, 2025 | |
TDOC Teladoc Health | Maintains: Equal-Weight | $10 → $8 | $7.23 | +10.65% | 3 | May 8, 2025 | |
GDRX GoodRx Holdings | Maintains: Overweight | $8 → $7 | $3.48 | +101.15% | 8 | Apr 29, 2025 | |
HQY HealthEquity | Maintains: Overweight | $110 → $125 | $87.56 | +42.76% | 9 | Feb 26, 2025 |
Health Catalyst
Aug 11, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $3.07
Upside: +95.44%
Doximity
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $62 → $65
Current: $62.98
Upside: +3.21%
American Well
Aug 7, 2025
Maintains: Overweight
Price Target: $15 → $12
Current: $7.18
Upside: +67.13%
Omnicell
Jul 21, 2025
Maintains: Overweight
Price Target: $37 → $40
Current: $31.34
Upside: +27.63%
Veeva Systems
May 29, 2025
Maintains: Overweight
Price Target: $285 → $300
Current: $274.36
Upside: +9.35%
Teladoc Health
May 8, 2025
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $7.23
Upside: +10.65%
GoodRx Holdings
Apr 29, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $3.48
Upside: +101.15%
HealthEquity
Feb 26, 2025
Maintains: Overweight
Price Target: $110 → $125
Current: $87.56
Upside: +42.76%